Clobetasol Propionate

This contract pertains to the supply of Clobetasol Propionate 0.05% solution, a topical medication used for dermatological treatments. The contract, identified by the solicitation number SPE2D2-23-D-0011, was posted on August 8, 2025, and is managed by the Department of Defense's DLA Troop Support organization, located in Philadelphia, Pennsylvania. The performance of the contract will take place in Hauppauge, New York. The contract is associated with the NAICS code 325412, which covers pharmaceutical and medicine manufacturing. Key points include the primary points of contact being Keith Ryales and Jason Wray, both reachable via email and phone for inquiries. The contract does not specify set-aside categories or size, indicating it may be open or unspecified in scope. The procurement is part of the Department of Defense’s efforts to secure essential medical supplies, and additional details can be accessed through the provided link on SAM.gov.